4.8 News Item

Sniffing out lung cancer

期刊

NATURE NANOTECHNOLOGY
卷 4, 期 10, 页码 621-622

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nnano.2009.285

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Critical Care Medicine

Impact of the Percepta Genomic Classifier on Clinical Management Decisions in a Multicenter Prospective Study

Hans J. Lee, Peter Mazzone, David Feller-Kopman, Lonny Yarmus, Kyle Hogarth, Lori R. Lofaro, Bailey Griscom, Marla Johnson, Yoonha Choi, Jing Huang, Sangeeta Bhorade, Avrum Spira, Giulia C. Kennedy, Momen M. Wahidi

Summary: The Percepta genomic classifier can decrease the need for additional invasive procedures in patients with low/intermediate risk lung nodules, leading to a change in management plan from invasive procedure to surveillance for the majority of patients up to 12 months after initial evaluation.
Article Radiology, Nuclear Medicine & Medical Imaging

Multicenter Study of Temporal Changes and Prognostic Value of a CT Visual Severity Score in Hospitalized Patients With Coronavirus Disease (COVID-19)

Xiaofeng Wang, Xingxing Hu, Weijun Tan, Peter Mazzone, Eduardo Mireles-Cabodevila, Xiaozhen Han, Pingyue Huang, Weihua Hu, Raed Dweik, Zhenshun Cheng

Summary: The study found that CT visual severity score can guide treatment and predict complications in hospitalized COVID-19 patients. It was discovered that CT visual severity score is associated with clinical disease severity and evolves during hospitalization.

AMERICAN JOURNAL OF ROENTGENOLOGY (2021)

Letter Critical Care Medicine

Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial

Nichole T. Tanner, Steven C. Springmeyer, Alex Porter, James R. Jett, Peter Mazzone, Anil Vachani, Gerard A. Silvestri

Article Critical Care Medicine

Phenotypes and Subphenotypes of Patients With COVID-19 A Latent Class Modeling Analysis

Xiaofeng Wang, Lara Jehi, Xinge Ji, Peter J. Mazzone

Summary: The study identified distinct phenotypes and subphenotypes of COVID-19 patients through latent class analysis, which may guide basic, clinical, and translational research efforts. Among the 20,572 patients analyzed, different phenotypes and subphenotypes were identified, aiding in stratified analyses in clinical trials and characterizing the pathobiology of COVID-19 presentations for basic science researchers.
Article Critical Care Medicine

Proposed Quality Metrics for Lung Cancer Screening Programs A National Lung Cancer Roundtable Project

Peter J. Mazzone, Charles S. White, Ella A. Kazerooni, Robert A. Smith, Carey C. Thomson

Summary: Screening for lung cancer with low radiation dose chest CT scans is the standard of care for eligible individuals. Quality indicators can help programs evaluate their practice and develop improvement plans.
Editorial Material Critical Care Medicine

A Year of Progress and Learning

Peter J. Mazzone

Meeting Abstract Oncology

Early candidate nasal swab classifiers developed using machine learning and whole transcriptome sequencing may improve early lung cancer detection.

Peter J. Mazzone, Carla Lamb, Kimberly M. Rieger-Christ, Chakravarthy B. Reddy, Jianghan Qu, Shuyang Wu, Jie Ding, Duncan Whitney, Daniel G. Pankratz, Joshua Babiarz, Lori Lofaro, P. Sean Walsh, Jonathon Wilde, Sangeeta Maruti Bhorade, Jing Huang, Giulia Kennedy, Avrum Spira

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Definition and assessment of high risk in patients considered for lobectomy for stage I non-small cell lung cancer: The American Association for Thoracic Surgery expert panel consensus document

Arjun Pennathur, Alessandro Brunelli, Gerard J. Criner, Homa Keshavarz, Peter Mazzone, Garrett Walsh, James Luketich, Michael Liptay, Q. Eileen Wafford, Sudish Murthy, M. Blair Marshall, Betty Tong, Michael Lanuti, Andrea Wolf, Brian Pettiford, Billy W. Loo, Robert E. Merritt, Gaetano Rocco, Matthew Schuchert, Thomas K. Varghese, Scott J. Swanson

Summary: Lobectomy is a standard treatment for stage I non-small cell lung cancer, but a significant proportion of patients may be at high risk for complications, including mortality. The expert panel identified important risk factors for assessing high risk patients, such as the need for supplemental oxygen, low diffusion capacity, frailty, and overall daily activity assessment. Age was determined to be less important in risk assessment relative to other factors, and a minimally invasive approach is increasingly critical in older populations to mitigate risk.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2021)

Meeting Abstract Critical Care Medicine

A NASAL CLINICAL-GENOMIC CLASSIFIER FOR ASSESSING RISK OF MALIGNANCY IN LUNG NODULES DEMONSTRATES ACCURATE PERFORMANCE INDEPENDENT OF NODULE SIZE OR CANCER STAGE

Carla Lamb, Kimberly Rieger-Christ, Chakravarthy Reddy, Jie Ding, Jianghan Qu, Shuyang Wu, Marla Johnson, Duncan Whitney, Patric Walsh, Jonathan Wilde, Sangeeta Bhorade, William Bulman, Lori Lofaro, Jing Huang, Avi Spira, Giulia Kennedy, Peter Mazzone

Review Medicine, General & Internal

Evaluating the Patient With a Pulmonary Nodule A Review

Peter J. Mazzone, Louis Lam

Summary: Pulmonary nodules are common and most of them are benign. The management of pulmonary nodules should be guided by the probability of malignancy, safety of testing, informativeness of additional testing, and patient preferences.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Medicine, General & Internal

Characteristics of Persons Screened for Lung Cancer in the United States A Cohort Study

Gerard A. Silvestri, Lenka Goldman, Judy Burleson, Michael Gould, Ella A. Kazerooni, Peter J. Mazzone, M. Patricia Rivera, V. Paul Doria-Rose, Lauren S. Rosenthal, Michael Simanowith, Robert A. Smith, Nichole T. Tanner, Stacey Fedewa

Summary: This study aimed to investigate the sociodemographic characteristics and adherence among lung cancer screening recipients in the United States. The study found that approximately 91% of the screened population met the USPSTF eligibility criteria, and older age, female gender, and current smoking were associated with higher likelihood of screening. However, adherence to annual follow-up screening was poor, potentially limiting the effectiveness of screening.

ANNALS OF INTERNAL MEDICINE (2022)

Article Medicine, General & Internal

Lung Cancer Screening

Humberto K. Choi, Peter J. Mazzone

MEDICAL CLINICS OF NORTH AMERICA (2022)

Meeting Abstract Oncology

DELFI-L101: Development of a Blood-Based Assay That Evaluates Cell-Free DNA Fragmentation Patterns to Detect Lung Cancer

P. J. Mazzone, V. Velculescu, D. Dix, S. Kotagiri, L. M. Sun, S. Allen, D. Jakubowski, A. Leal, R. B. Scharpf, P. B. Bach, T. Maddala

JOURNAL OF THORACIC ONCOLOGY (2022)

Meeting Abstract Oncology

DELFI-L101: Development of a blood-based assay that evaluates cell-free DNA fragmentation patterns to detect lung cancer

Peter J. Mazzone, Kyle Work, Victor E. Velculescu, Sonali Kotagiri, Lee Ming Sun, Daniel Dix, Debbie M. Jakubowski, Alessandro Leal, Peter Brian Bach, Tara Maddala

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Respiratory System

Association of Exercise Behavior with Overall Survival in Stage I-IIIA Lung Cancer

Duc M. Ha, Chan Zeng, Edward D. Chan, Mark Gray, Peter J. Mazzone, Jonathan M. Samet, John F. Steiner

Summary: The study found that prediagnosis active exercise was associated with better overall survival in patients with stage I-IIIA lung cancer.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)

暂无数据